Dr. Alan Kiyoshi Okada, MD, PhD

Dr. Okada practices at Fairview Range Hospital in Hibbing, Minnesota, part of Fairview Health Services.

Dr. Okada's NPI, 1881188043, was assigned on June 20, 2018. Dr. Okada graduated from University of Southern California Keck School of Medicine in 2018. Dr. Okada holds Minnesota license 69133.

Dr. Okada's primary practice is Fairview Range Hospital, at 750 East 34th St, Hibbing, MN 55746 in St. Louis County. The practice phone is (218) 362-6730.

Dr. Okada's primary practice is Fairview Range Hospital in Hibbing, Minnesota, part of Fairview Health Services. Dr. Okada is also affiliated with Grand Itasca Clinic & Hospital. The medical group on file is Fairview Range. Dmand AI also links Dr. Okada to 1 more medical group, named with a free account. Dr. Okada's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Okada practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Okada's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Okada is licensed in Minnesota.

CMS data shows 193 Medicare services from Dr. Okada across 3 procedure codes in 2024, for 193 Medicare patients. Medicare paid $15,508 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 193 Medicare patients who saw Dr. Okada in 2024. The largest group is under 65, with 72 patients. 72% of them have high blood pressure, and 62% have high cholesterol. 47% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Okada's median patient age at 72, with 54% women.

In 2024, Dr. Okada wrote 263 Medicare Part D claims for 180 patients. 95% of them were for generic drugs. CMS names the drug for 139 of them, across 7 drugs with 11 or more claims each, at $867 in total drug cost. In 2023, CMS named 112 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Okada for performance year 2024, reported as part of a group. Dr. Okada accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Okada, published from 2016 to 2021. 2021 was the busiest year, with 2. Dr. Okada has published most often in Nat Commun. Dr. Okada's most frequent co-authors are Gregory W. Albers, MD, Sahar Bedrood, MD, PhD and Richard A. Bernstein, MD.

Dr. Okada graduated from University of Southern California Keck School of Medicine in 2018.